Literature DB >> 24470254

Apoptotic osteocytes and the control of targeted bone resorption.

Lilian I Plotkin1.   

Abstract

Studies from the 1950s and 1960s already recognize the fact that osteocytes, although long living cells, die, as evidenced by accumulation of osteocytic lacunae devoid of cells. More recently, it was demonstrated that these cells die by apoptosis. The rate of osteocyte apoptosis is regulated by the age of the bone, as well as by systemic hormones, local growth factors, cytokines, pharmacological agents, and mechanical forces. Apoptotic osteocytes, in turn, recruit osteoclasts to initiate targeted bone resorption. This results in the removal of "dead" bone and may improve the mechanical properties of the skeleton. However, the molecular regulators of osteocyte survival and targeted bone remodeling are not completely known. In this review, the current knowledge on the molecular mechanism that lead to osteocyte death or survival, and the signals that mediate targeted bone resorption is discussed.

Entities:  

Mesh:

Year:  2014        PMID: 24470254      PMCID: PMC3952244          DOI: 10.1007/s11914-014-0194-3

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  60 in total

1.  Apoptotic bone cells may be engulfed by osteoclasts during alveolar bone resorption in young rats.

Authors:  F Boabaid; P S Cerri; E Katchburian
Journal:  Tissue Cell       Date:  2001-08       Impact factor: 2.466

2.  Connexin43 interacts with βarrestin: a pre-requisite for osteoblast survival induced by parathyroid hormone.

Authors:  Nicoletta Bivi; Virginia Lezcano; Milena Romanello; Teresita Bellido; Lilian I Plotkin
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

3.  Severe Spinal Cord Injury Causes Immediate Multi-cellular Dysfunction at the Chondro-Osseous Junction.

Authors:  Leslie R Morse; Yan Xu; Bethlehem Solomon; Lara Boyle; Subbiah Yoganathan; Philip Stashenko; Ricardo A Battaglino
Journal:  Transl Stroke Res       Date:  2011-12-01       Impact factor: 6.829

4.  Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.

Authors:  J Ignacio Aguirre; Lilian I Plotkin; Scott A Stewart; Robert S Weinstein; A Michael Parfitt; Stavros C Manolagas; Teresita Bellido
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

5.  Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip.

Authors:  R S Weinstein; R W Nicholas; S C Manolagas
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

6.  Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.

Authors:  Nicoletta Bivi; Keith W Condon; Matthew R Allen; Nathan Farlow; Giovanni Passeri; Lucas R Brun; Yumie Rhee; Teresita Bellido; Lilian I Plotkin
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

7.  Identification of apoptotic changes in osteocytes in normal and pathological human bone.

Authors:  B S Noble; H Stevens; N Loveridge; J Reeve
Journal:  Bone       Date:  1997-03       Impact factor: 4.398

8.  Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice.

Authors:  Robert S Weinstein; Chao Wan; Qinglan Liu; Ying Wang; Maria Almeida; Charles A O'Brien; Jeff Thostenson; Paula K Roberson; Adele L Boskey; Thomas L Clemens; Stavros C Manolagas
Journal:  Aging Cell       Date:  2009-12-28       Impact factor: 9.304

9.  Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.

Authors:  Teresita Bellido; A Afshan Ali; Lilian I Plotkin; Qiang Fu; Igor Gubrij; Paula K Roberson; Robert S Weinstein; Charles A O'Brien; Stavros C Manolagas; Robert L Jilka
Journal:  J Biol Chem       Date:  2003-10-01       Impact factor: 5.157

10.  A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction.

Authors:  J Ignacio Aguirre; Lilian I Plotkin; Arancha R Gortazar; Marta Martin Millan; Charles A O'Brien; Stavros C Manolagas; Teresita Bellido
Journal:  J Biol Chem       Date:  2007-07-03       Impact factor: 5.157

View more
  29 in total

Review 1.  Osteocytic signalling pathways as therapeutic targets for bone fragility.

Authors:  Lilian I Plotkin; Teresita Bellido
Journal:  Nat Rev Endocrinol       Date:  2016-05-27       Impact factor: 43.330

Review 2.  Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects.

Authors:  Barbara M Misof; Nadja Fratzl-Zelman; Eleftherios P Paschalis; Paul Roschger; Klaus Klaushofer
Journal:  Bonekey Rep       Date:  2015-02-11

3.  Elevations in Cortical Porosity Occur Prior to Significant Rise in Serum Parathyroid Hormone in Young Female Mice with Adenine-Induced CKD.

Authors:  Corinne E Metzger; Elizabeth A Swallow; Matthew R Allen
Journal:  Calcif Tissue Int       Date:  2019-12-12       Impact factor: 4.333

4.  Osteocytic miR21 deficiency improves bone strength independent of sex despite having sex divergent effects on osteocyte viability and bone turnover.

Authors:  Hannah M Davis; Padmini J Deosthale; Rafael Pacheco-Costa; Alyson L Essex; Emily G Atkinson; Mohammad W Aref; Julian E Dilley; Teresita Bellido; Mircea Ivan; Matthew R Allen; Lilian I Plotkin
Journal:  FEBS J       Date:  2019-10-08       Impact factor: 5.542

5.  Screening of key candidate genes and pathways for osteocytes involved in the differential response to different types of mechanical stimulation using a bioinformatics analysis.

Authors:  Ziyi Wang; Yoshihito Ishihara; Takanori Ishikawa; Mitsuhiro Hoshijima; Naoya Odagaki; Ei Ei Hsu Hlaing; Hiroshi Kamioka
Journal:  J Bone Miner Metab       Date:  2018-11-09       Impact factor: 2.626

6.  Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.

Authors:  Lilian I Plotkin; Arancha R Gortazar; Hannah M Davis; Keith W Condon; Hugo Gabilondo; Marta Maycas; Matthew R Allen; Teresita Bellido
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

Review 7.  Mechanobiology of Bone Metastatic Cancer.

Authors:  Blayne A Sarazin; Claire L Ihle; Philip Owens; Maureen E Lynch
Journal:  Curr Osteoporos Rep       Date:  2021-11-03       Impact factor: 5.096

Review 8.  MicroRNAs and osteocytes.

Authors:  Lilian I Plotkin; Joseph M Wallace
Journal:  Bone       Date:  2021-05-07       Impact factor: 4.626

Review 9.  Role of osteocytes in multiple myeloma bone disease.

Authors:  Jesus Delgado-Calle; Teresita Bellido; G David Roodman
Journal:  Curr Opin Support Palliat Care       Date:  2014-12       Impact factor: 2.302

10.  The role of inhibition of osteocyte apoptosis in mediating orthodontic tooth movement and periodontal remodeling: a pilot study.

Authors:  Michele Kaplan; Zana Kalajzic; Thomas Choi; Imad Maleeh; Christopher L Ricupero; Michelle N Skelton; Madeleine L Daily; Jing Chen; Sunil Wadhwa
Journal:  Prog Orthod       Date:  2021-07-26       Impact factor: 2.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.